Document Detail

Basal cell carcinoma presenting as finger mass. A case report.
MedLine Citation:
PMID:  7900712     Owner:  NLM     Status:  MEDLINE    
Basal cell carcinomas (BCC) are common skin lesions generally recognized by characteristic features. Several varieties are described, a few of which are atypical and rarely affects the hand. The authors present a case consistent with basal cell carcinoma, occurring in a 64-year-old white male, who developed swelling of the distal phalanx of the right middle finger over a period of approximately 5 years. On review of the literature regarding basal cell carcinomas, the authors found only 12 cases of BCC on the digits of the hand or foot, all of which were either periungual or subungual. Usually located in the skin of the head and face, this locally destructive neoplasm is rare for the volar surface of the finger. Metastases does not often occur with a BCC and prognosis for this tumor is excellent with total resection.
L Bhagchandani; R E Sanadi; S Sattar; R R Abbott
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of clinical oncology     Volume:  18     ISSN:  0277-3732     ISO Abbreviation:  Am. J. Clin. Oncol.     Publication Date:  1995 Apr 
Date Detail:
Created Date:  1995-04-27     Completed Date:  1995-04-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8207754     Medline TA:  Am J Clin Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  176-9     Citation Subset:  IM    
Department of Medicine, Hurley Medical Center, Flint, Michigan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma, Basal Cell / pathology*,  surgery
Middle Aged
Skin Neoplasms / pathology*,  surgery

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomitin...
Next Document:  Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.